Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT02296775 · COMPLETED
Trial details
- NCT number
- NCT02296775
- Sponsor
- Dr. Reddy's Laboratories Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-11-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.